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2 
Abstract  1 
Chronic non-healing wounds are a major health problem with resident bacteria 2 
strongly implicated in their impaired healing.  A rapid-screen to provide detailed 3 
knowledge of wound bacterial populations would therefore be of value and help 4 
prevent unnecessary and indiscriminate use of antibiotics; a process associated 5 
with promoting antibiotic resistance.  We analysed chronic wound fluid samples, 6 
which had been assessed for microbial content, using 20 different fluorimetric 7 
peptide substrates to determine whether protease activity correlated with the 8 
bacterial load.  Eight of the peptide substrates showed significant release of 9 
fluorescence after reaction with some of the wound samples.  Comparison of 10 
wound fluid protease activities with the microbiological data indicated that there 11 
was no correlation between bacterial counts and enzyme activity for most of the 12 
substrates tested.  However, two of the peptide substrates produced a signal 13 
corresponding with the microbial data revealing a strong positive correlation 14 
with Pseudomonas aeruginosa numbers.  This demonstrated that short 15 
fluorescent peptides can be used to detect protease activity in chronic wound 16 
fluid samples.  The finding that two peptides were specific indicators for the 17 
presence of P. aeruginosa may be the basis for a diagnostic test to determine 18 
wound colonisation by this organism.  19 
 20 
Keywords: chronic venous leg ulcer; AMC-peptides; Staphylococcus aureus; 21 
Pseudomonas aeruginosa; bacterial protease; chronic infection; skin wounds  22 
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3 
Introduction  1 
Chronic non-healing skin wounds are a major world health problem; occurring in 2 
three main forms, pressure ulcers, venous leg ulcers and diabetic foot ulcers.  3 
These wounds represent an unrecognised cause of disability and distress in the 4 
aged population [1] and, importantly, are estimated to consume 2–4% of the 5 
total healthcare budget in European Union countries [2, 3].  The incidence of 6 
these wounds is rising inexorably with the increased age of the population and 7 
corresponding increases in obesity and type II diabetes.  These additional 8 
comorbidities often result in lower limb amputations and sepsis as frequent 9 
chronic wound complications.  Uncertainty about the effectiveness of the 10 
various wound dressings available [4] highlights the ambiguities involved in the 11 
treatment of venous ulcers.   12 
Whilst the aetiology of chronic wounds is multi-factorial, bacteria play an 13 
important direct and indirect role in the chronicity of the disease [5].  Through 14 
production of proteases and other metabolites, bacteria may both modulate 15 
responses in the resident cellular populations and directly degrade extracellular 16 
matrix.  Additionally, bacteria also stimulate innate and adaptive inflammatory 17 
responses in the dermis with the generation of oxidative stress in the wound 18 
environment [6].  Wounds support a diverse microflora [7].  The importance of 19 
anaerobic organisms in perpetuating wounds has been observed both in vivo [5, 20 
8] and in vitro [6], although relatively few detailed microbiological studies have 21 
been undertaken [9].  Pseudomonas aeruginosa and Staphylococcus aureus 22 
are the most frequently isolated aerobic species from these wounds [5, 9]; both 23 
species being opportunistic pathogens commonly found colonising healthy skin 24 
[10].  Staphylococcus aureus can be highly pathogenic when invading the skin 25 
barrier [11], and impairs wound-healing via the expression of a wide range of 26 
virulence factors.  In the wound environment, the formation of P. aeruginosa 27 
biofilms results in significantly larger ulcers and delayed wound-healing [10] and 28 
contributes to antibiotic resistance, particularly ciprofloxacin [12].  29 
Rapid analysis of bacteria populating particular wounds would be extremely 30 
useful in clinical practice, avoiding unnecessary and arbitrary use of antibiotics, 31 
with its known promotion of antimicrobial resistance [13].  Unfortunately, current 32 
microbiological analysis of wound fluid samples takes 48-72 h for aerobic 33 
species and over 7 days for slow-growing strictly anaerobic bacteria.  34 
4 
Consequently, antibiotic prescribing for these patients is largely empirical with 1 
the over-prescription of antibiotics [13] and antimicrobial resistance being a 2 
common feature in these wounds [9].  3 
Bacterial enzymes released into the local environment can be measured 4 
using well established analytical processes based on chromogenic or 5 
fluorogenic substrate assays.  Proteases have great potential as specific 6 
markers of infection.  Novel approaches to infection treatment based on 7 
proteases have been extensively researched [14, 15] with the emphasis being 8 
on reducing protease activity in the wound using absorbent dressings [16, 17] or 9 
protease inhibitors [18, 19].  Bacterial proteases released into the wound 10 
environment have a variety of effects on defence and healing mechanisms.  11 
These include the activation of matrix metalloproteinases (MMPs) by proteolytic 12 
removal of the inhibitory pro-domains [20], targeting the fibrinolytic system [21] 13 
and affecting macrophage activity [22].  Bacterially secreted endoproteases, 14 
quantified using fluorescent peptide substrates, can be used for direct 15 
identification of specific pathogenic bacteria [23].  Wildeboer et al. [23] showed 16 
that protease activity, analysed using short peptide libraries, was most sensitive 17 
and specific for the detection and quantification of P. aeruginosa.  Hence, 18 
characterising protease activity in wound fluid samples, with substrates that 19 
specifically detect bacterial proteases, holds potential for a rapid diagnosis.   20 
In the present study, the objective was to identify protease activity against 21 
specific peptide substrates that correlated with the bacterial load of wound fluid 22 
samples from patients with chronic infected wounds, particularly P. aeruginosa.  23 
 24 
Materials and Methods  25 
 26 
Chemicals and reagents  27 
Chemicals and reagents, if not specified otherwise, were obtained from Sigma-28 
Aldrich (Poole, UK).  Peptides were purchased from Sigma-Aldrich, Bachem 29 
(St. Helens, UK), Biomol (Exeter, UK) and Calbiochem (Nottingham, UK).  30 
Twenty different peptides labeled with a carboxy-terminal 7-amino-4-31 
methylcoumarin (AMC) were included in this study (Table 1).  32 
 33 
Patients  34 
5 
Following local research ethics committee approval and after obtaining patient 1 
informed written consent, patients with chronic venous leg ulceration attending 2 
the Wound Healing Research Unit, University Hospital of Wales, Cardiff, UK 3 
were recruited to provide swab and wound fluid samples.  Patients were 4 
selected that had highly exudating wounds and included four male and six 5 
female patients (Table 2).  The participant’s ages ranged from 62 to 88 years, 6 
with a mean age of 74.1 ± 9.2 years and wound duration ranging from 10 7 
months to 27 years.  The wounds were all located on the lower legs, with one a 8 
malleolus wound, four semi-circumferential and five circumferential wounds.  9 
Ulcer causation was venous disease in five cases, one burn, one trauma and 10 
four of unknown aetiology.  The patients were receiving a range of medication.  11 
Three patients with infected wounds, assessed by experienced wound healing 12 
experts, were taking oral antibiotics at the time of wound fluid sampling.  Also of 13 
note, participant 2 was also using potassium permanganate soaks, a topical 14 
treatment effective against Pseudomonas.   15 
 16 
Wound fluid samples 17 
Wound fluid from patients was collected using a totally non-invasive method by 18 
extracting the fluid from wound dressings [24].  At the same time, a 19 
microbiological sample of the wound surface was obtained using Amies 20 
charcoal transport swabs (Sterilin, Newport, UK).  Samples were transported to 21 
the microbiology laboratory where the wound fluid was eluted no later than 30 22 
min after removal of the dressing from the wound.  The dressings were cut into 23 
5 cm x 5 cm squares placed in a sterile Petri-dish with 12.5 mL of wound fluid 24 
elution buffer (0.1 M Tris-HCl, pH 7.4, 0.1% Triton X-100) and agitated on a tilt 25 
board at 4°C for 4 h.  The fluid was squeezed out of each dressing using sterile 26 
forceps and the eluate of each dressing recombined in a sterile bottle.  A 100 27 
µL portion of this fluid was removed for microbial analysis.  Wound fluid 28 
samples were aliquoted and stored at -80°C in a locked Human Tissue 29 
Authority approved freezer.  30 
 31 
Microbiological analysis of wound fluid samples 32 
Microbial swab samples were streaked onto non-selective media plates to 33 
assess for the presence of bacteria in the wounds.  Wound fluid samples were 34 
6 
extracted from dressings as described above, serially diluted in phosphate 1 
buffered saline (137 mM NaCl, 3 mM KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4, pH 2 
7.4, PBS) and plated on to selective and non-selective media.  Pseudomonas 3 
agar (PA, LabM, Bury, UK) supplemented with 200 mg/L cetrimide and 15 mg/L 4 
nalidixic acid was used for detection of P. aeruginosa, and colony identification 5 
confirmed by colony morphology, Gram-stain, oxidase and catalase tests as 6 
well as PCR.  Mannitol salt agar (MSA, Oxoid, Basingstoke, UK) was used for 7 
the detection of S. aureus.  Staphylococcus aureus grow as yellow colonies on 8 
MSA and identity was further confirmed by Gram-stain and coagulase tests.  9 
Blood agar (BA, LabM, Bury, UK) was used for non-selective culture of the 10 
whole microflora to obtain a total microbial count for each wound fluid sample.  11 
 12 
Protein quantification in wound fluid samples 13 
The total protein concentration of the wound fluid samples was quantified using 14 
a BCA kit (Novagen–Merck, Darmstadt, Germany) following the standard 15 
protocol for the micro-scale assay.  The chronic wound fluid samples were 16 
diluted 1:5 and 1:20 in Tris-buffered saline (137 mM NaCl, 10 mM Tris-HCl, pH 17 
7.3, TBS) prior to assaying.  Absorbance was measured at 584 nm in a micro-18 
plate reader (FLUOstar OPTIMA, BMG Labtech, Offenburg, Germany) and 19 
analysed with the accompanying MARS software using a simultaneously 20 
recorded bovine serum albumin reference curve.  21 
 22 
Fluorescent assay of protease activity with peptide-AMC substrates 23 
Peptide-AMC substrates were dissolved in DMSO at 5 mg/ml and diluted to 50 24 
µM in PBS.  Wound fluid samples were prepared as described above and 25 
diluted prior to the assay with an equal volume of Tris buffered saline (137 mM 26 
NaCl, 10 mM Tris, pH 7.3, TBS).  Aliquots of 10 µl of 50 µM peptide-AMC were 27 
pipetted into the wells of a black 96 well micro-titre plate (Greiner, Stonehouse, 28 
UK) and 90 µl of wound fluid sample added.  The final concentration of 29 
substrates in the reaction mix was 5 µM.  Fluorescence (excitation wavelength 30 
355 nm, emission wavelength 450 nm) was measured at intervals from the start 31 
of the reaction for 12 h following the addition of the wound fluid in a FLUOstar 32 
OPTIMA plate reader.  Measurements were taken at 5 min intervals for the first 33 
7 
1 h and then every 30 min.  Results were corrected for the background 1 
fluorescence of the wound fluid sample, as well as for the peptide-AMC.   2 
 3 
Results  4 
 5 
Microbial status of the wound fluid samples 6 
Pseudomonas aeruginosa was found to be present in all samples bar one, with 7 
limited growth seen in sample 1 (Table 2).  Coagulase negative staphylococci 8 
(CNS) were found in six of the samples and S. aureus in five, with samples 3 9 
and 4 containing both organisms.  Other organisms detected included Proteus 10 
and Corynebacterium spp.  11 
 12 
Total protein content of chronic wound fluid samples 13 
The total protein concentration in the wound fluid samples ranged between 873 14 
µg/mL and 510 µg/mL, with a mean of 697 µg/mL and a median of 719 µg/mL 15 
(Table 2).  The total protein concentration did not correlate with any of the 16 
quantitative bacterial counts or protease activity detected with the fluorescent 17 
peptides.  18 
 19 
Specific protease activity in wound fluid samples 20 
Aliquots from ten chronic wound fluid samples (Table 2) were assayed with 21 
each of the peptide-AMC substrates (Table 1) to determine protease activity.  22 
Reaction and measurement conditions were optimised for maximum sensitivity 23 
and a rapid, but reliable response.  Eight substrates out of the 20 tested showed 24 
a significant increase in fluorescence over the 12 h reaction time with all or 25 
some of the ten wound fluid samples.  The slope of the initial linear phase was 26 
used to calculate enzyme activity against these eight substrates, as shown for 27 
samples numbers three and six (Fig. 1).  Figure 2 shows a single point analysis 28 
of the fluorescence intensity after 1 h reaction time for all 10 wound fluid 29 
samples with the eight substrates showing the strongest response.   30 
Analysis of protease activities obtained using the peptide-AMC substrates for 31 
a relationship with the microbiological data showed a positive correlation for 32 
initial enzyme activity, and for 60 min and 6 h signal intensity, with the microbial 33 
counts for P. aeruginosa.  Scatter plots of all the data indicated that there was 34 
8 
no correlation between bacterial count and enzyme activity for most of the 1 
substrates.  However, Pearson correlation analysis confirmed that enzyme 2 
activity measured with two of the 20 peptide-AMC substrates tested (VLK and 3 
AFK) were positively correlated with the P. aeruginosa quantitative microbial 4 
counts from the ten wound fluid samples (p<0.01, r>0.8, Table 3).  There was 5 
only limited evidence for a moderate relationship between enzyme activity and 6 
S. aureus counts, and insufficient evidence for a relationship with total bacterial 7 
numbers (Table 3).  Regression analysis of the 6 h data, using the AFK 8 
substrate with the ten wound fluid samples, revealed that enzyme activity 9 
against this substrate was a sufficient predictor of the number of P. aeruginosa 10 
found in the wound fluid sample (R2 = 72%, Fig. 3A) but not for S. aureus (R2 < 11 
35%, Fig. 3B) or total number of bacteria (Fig. 3C).  12 
 13 
Discussion  14 
Bacterial proteases are a promising target for the analysis of infected wounds 15 
[25, 26] with the ultimate aim being to improve patient treatment regimes and 16 
overcome the limitations of currently employed antimicrobial therapies; often 17 
prescribed empirically.  Previous work, using purified bacterial proteases and 18 
cultivated clinical isolates of P. aeruginosa, has shown that assays with specific 19 
peptide substrates can be used to rapidly quantify bacterial pathogens in a 20 
given sample [23].  Furthermore, recent identification and characterisation of 21 
proteases specific for pathogenic organisms [27, 28] holds possibilities for the 22 
development of more specific novel diagnostic approaches as a possible 23 
addition to currently employed microbiological and molecular methods.  To 24 
achieve this goal, assays are required, which allow testing without the need for 25 
lengthy purification steps of the patient sample, and which then produce robust 26 
and rapid quantitative results.   27 
The data presented showed that specific peptide substrates could be used to 28 
quantify protease activity in ex vivo samples from chronic infected wounds.  We 29 
also demonstrated that rapid analysis could be directly achieved with these 30 
patient wound samples.  However, only two of the wide range of peptide 31 
substrates screened, were identified as having efficacy as specific indicators for 32 
the presence of P. aeruginosa in wounds.  None proved appropriate for 33 
detection of S. aureus.   34 
9 
Bacterial proteases play an important role in pathogenicity [29] and 1 
Pseudomonas proteases have been shown to play a significant role in keratitis, 2 
affecting both host defence and healing mechanisms [30].  Hence, profiling of 3 
protease activity in a wound fluid sample could provide important information on 4 
wound healing, particularly if wound proteases were measured over time.  5 
Furthermore, the identification of species-specific substrates could be the first 6 
step to developing specific inhibitory molecules that might limit the pathogenicity 7 
of an infecting organism, not only by improving the host’s ability to overcome 8 
infection but also by promoting wound healing.   9 
A number of the patients included in this study had received various forms of 10 
treatment with bactericidal agents.  However, five of the ten samples showed P. 11 
aeruginosa counts of > 1 x 106 cfu/mL; with the extracted wound fluid of only 12 
one patient being negative for this organism.  This implies that P. aeruginosa 13 
remained largely unaffected by the antimicrobial treatment regimens being 14 
used; highlighting the importance of specifically quantifying and targeting this 15 
organism.  Previous studies have shown that P. aeruginosa  is often under 16 
represented by microbial culture, being present in unculturable form [5].  17 
Formation of biofilms by P. aeruginosa in infected wounds delayed healing in a 18 
diabetic mouse model [31], demonstrating the importance of detecting and 19 
targeting this organism in wound healing therapy.  20 
Statistical analysis revealed a significant correlation for only two of the 20 21 
substrates tested.  The identified substrate, Suc-AFK-AMC, had previously 22 
been shown to be a good marker for P. aeruginosa protease activity using 23 
cultured reference strains [23].  The second positive substrate, Boc-VLK-AMC, 24 
also cleaved the carboxy-terminal of a lysine residue, indicating that this may be 25 
a key element in its substrate specificity.  Further studies are needed to identify 26 
the importance of the remaining peptide amino acids present and to explore the 27 
possibility of increasing substrate-specificity by modification of these.  Test 28 
conditions in this study were optimised in such a way that significant results 29 
could be obtained within a 1 h reaction time.  Further testing of a larger number 30 
of patient samples will be required to confirm these results, and to obtain further 31 
insight into the effect that previous patient antimicrobial treatments may have on 32 
test outcomes.  Our results demonstrate that a rapid test, based on specific 33 
enzyme activity, holds exciting potential for identifying pathogenic organisms 34 
10 
directly from patient samples such as wound fluid, without the need for time-1 
consuming processing or purification.  Such systems could ultimately become 2 
useful prognostic indicators of non-healing in the wound healing clinic and 3 
hence a significant aid to patient treatment. 4 
 5 
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Tables  1 
 2 
Table 1.  Amino acid sequences of the 20 peptide-AMC substrates 3 
included in this study.  Peptide amino acid sequences read from amino to the 4 
carboxy terminus, with all having a 7-amino-4-methylcoumaryl group (AMC) at 5 
the carboxy-terminus.  Some of the peptides also carry a protective group at the 6 
α-amino group of their first amino acid.   7 
 8 
No Peptide substrate abbreviation 
1 AAF-AMC 
2 Suc-AAF-AMCa 
3 Z-GGL-AMCb 
4 Z-LLE-AMCb 
5 Suc-AFK-AMCa 
6 Boc-QAR-AMCc 
7 Boc-VPR-AMCc 
8 PFR-AMC 
9 Suc-LLVY-AMCa 
10 Z-RLRGG-AMCb 
11 Z-AAN-AMCb 
12 Z-GAM-AMCb 
13 Z-GAH-AMCb 
14 Suc-IIW-AMCa 
15 Boc-VLK-AMCc 
16 Z-GGR-AMCb 
17 Boc-GKR-AMCc 
18 MeOSuc-AAPV-AMCd 
19 Ac-DEVD-AMCe 
20 Suc-GPLGP-AMCa 
a
 Suc, succinyl  9 
b
 Z, carboxy benzoyl  10 
c
 Boc, tert. butyl-oxycarbonyl  11 
d
 MeOSuc, methoxy-succinyl  12 
e
 Ac, acetyl  13 
14 
14 
Table 2.  Summary of key patient data, P. aeruginosa quantification and 1 
total protein concentration in chronic wound fluid samples.  Concentration 2 
values displayed are the mean of two independent measurements, each carried 3 
out in triplicate.  4 
 5 
Patient 
no. 
Age 
(years) 
Sex Wound duration 
(months) 
Pseudomonas sp.a 
(cfu/mL)b  
Total protein 
(µg/mL)  
1 88 M 36 limited growth 873 
2 65 F 13 6.3 x 106 783 
3 84 M 216 6.5 x 104 827 
4 63 M 18 3.4 x 109 717 
5 68 F 216 4.5 x 106 721 
6 79 F 180 4.2 x 106 563 
7 80 F 10 n.d.c  562 
8 62 F 48 4.8 x 105 692 
9 74 F 17 1.6 x 104 720 
10 78 M 138 7.8 x 106 510 
a
 counts derived from Pseudomonas agar plates 6 
b
 cfu, colony forming units  7 
c
 not detected  8 
9 
15 
Table 3:  Pearson correlation of protease activity in chronic wound fluid 1 
samples using two peptide-AMC substrates (VLK and AFK).  Enzyme 2 
activity was measured as initial activity over 1 h and by single point analyses 3 
after 60 min and 6 h.  Bacterial counts for P. aeruginosa, Staphylococcus spp. 4 
and CNS) and total bacteria, obtained from chronic wound swab sample 5 
cultures on selective (PA and MSA) and BA are also shown.  6 
 7 
Peptidase activity 
with peptide-AMC 
Pearson 
correlation  
P. aeruginosa Staphylococcus 
spp. 
Total 
bacterial 
counts 
VLK initial rate  
 
ra  
pb  
0.840  
0.009  
0.683  
0.043  
0.526  
0.118  
 60 min  
 
ra  
pb 
0.864  
0.006  
0.675  
0.046  
0.524  
0.120  
 6 h  
 
ra  
pb 
0.860 
0.006 
0.634 
0.066 
0.561 
0.091 
AFK initial rate  
 
ra  
pb 
0.794  
0.019  
0.658  
0.054  
0.514  
0.128  
 60 min  
 
ra  
pb 
0.869  
0.005  
0.704  
0.034  
0.558  
0.094  
 6 h  
 
ra  
pb 
0.919 
0.001 
0.820 
0.007 
0.669 
0.035 
ar, Pearson correlation coefficient  8 
bp, probability value  9 
 10 
11 
16 
 1 
Figures  2 
3 
 4 
Fig. 1.  Initial protease activity plots for two selected wound fluid samples with 5 
the eight peptide-AMC substrates that showed the strongest response (A – 6 
patient sample 3, B – patient sample 6)  7 
8 
17 
 1 
 2 
Fig. 2.  Fluorescence intensity after 60 min reaction time of the wound fluid 3 
samples with the eight peptide-AMC substrates that showed the strongest 4 
response  5 
6 
18 
1 
 2 
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 1 
Fig. 3.  Regression analysis of quantitative bacterial counts for P. aeruginosa 2 
(A), S. aureus (B) and total bacterial count (C) with 6 h enzyme activity 3 
measured with Suc-AFK-AMC substrate  4 
 5 
